New eye implant aims to ease glaucoma pressure

NCT ID NCT05625958

Ongoing Disease control Sponsor: Ciliatech Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a small implant placed inside the eye to help drain fluid and lower pressure in people with open-angle or narrow-angle glaucoma. It is for adults whose eye pressure is not well controlled with eye drops. The main goal is to see if the implant safely reduces pressure and the need for pressure-lowering medications over 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA, NARROW ANGLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

angle-closure glaucoma chronic closed-angle glaucoma exfoliation syndrome open-angle glaucoma primary angle-closure glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA, NARROW ANGLE GLAUCOMA, OPEN-ANGLE

Contacts and locations

Locations

Hospital Clínic of Barcelona

Barcelona, 08028, Spain
Hospital Clínico San Carlos. Servicio de Oftalmología

Madrid, 28040, Spain
Hospital Clínico Universitario Lozano Blesa

Zaragoza, 50009, Spain
Hospital Universitario Miguel Servet. Servicio de Oftalmología.

Zaragoza, 50009, Spain
OMIQ Research

Sabadell, 08205, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.